Human adenovirus infection in kawasaki disease: a confounding bystander?
Clin. Infect. Dis., Jan;56(1):58-64 (2013)
Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropenia.
J. Pediatr. Hematol. Oncol., Aug;34(6):e241-5 (2012)
Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections.
PLoS ONE., 7(4):e34390 (2012)
Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.
J. Virol., May;86(10):5422-36 (2012)
A 2-month-old with bacteremia and gastroenteritis.
Pediatr. Infect. Dis. J., Feb;31(2):210, 215-6 (2012)
Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis.
Pediatr. Infect. Dis. J., Jan;31(1):86-9 (2012)
Challenges in infant immunity: implications for responses to infection and vaccines.
Nat. Immunol., Mar;12(3):189-94 (2011)
Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis.
Pediatrics., Dec;126(6):e1453-60 (2010)
Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.
Respir. Res., 11:125 (2010)
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.
Nature., Aug;466(7309):973-7 (2010)
Pericardial effusion complicating novel influenza A (H1N1) infection in an infant.
Pediatr. Infect. Dis. J., Aug;29(8):782-3 (2010)
Farewell to innocence: untangling septic shock in the postgenomic era.
Pediatr Crit Care Med., May;11(3):426-7 (2010)
Concomitant respiratory viral infections in children with Kawasaki disease.
Pediatr. Infect. Dis. J., Aug;29(8):770-2 (2010)
Viral coinfections in children with invasive pneumococcal disease.
Pediatr. Infect. Dis. J., Jun;29(6):519-23 (2010)
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
Pediatr. Infect. Dis. J., Mar;29(3):195-8 (2010)
Shifting the paradigm: host gene signatures for diagnosis of infectious diseases.
Cell Host Microbe., Sep;6(3):199-200 (2009)
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants.
Biologics., Sep;2(3):433-9 (2008)
Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections.
PLoS ONE., 4(5):e5446 (2009)
Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial.
Pediatr Allergy Immunol., Aug;20(5):477-85 (2009)
Respiratory syncytial virus persistence: evidence in the mouse model.
Pediatr. Infect. Dis. J., Oct;27(10 Suppl):S60-2 (2008)
Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection.
J. Infect. Dis., Dec;198(11):1667-76 (2008)
Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
J. Infect. Dis., Nov;198(10):1435-43 (2008)
MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus.
Proc. Natl. Acad. Sci. U.S.A., Sep;105(37):14046-51 (2008)
Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines.
Blood., Nov;112(9):3671-8 (2008)
Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections.
J Pediatr Orthop., 28(5):569-75 (2008 Jul-Aug)
Letters to the Editors.
Pediatr. Infect. Dis. J., Jan (2008)
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Pediatr. Infect. Dis. J., Dec;26(12):1089-93 (2007)
Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Pediatr. Infect. Dis. J., Nov;26(11):1053-6 (2007)
Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model.
Virol. J., 4:109 (2007)
Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey.
Pediatr. Infect. Dis. J., Oct;26(10):956-8 (2007)
The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature.
Pediatr. Infect. Dis. J., Aug;26(8):733-9 (2007)
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.
J. Exp. Med., Sep;204(9):2131-44 (2007)
Gene expression patterns in blood leukocytes discriminate patients with acute infections.
Blood., Mar;109(5):2066-77 (2007)
Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence.
Pediatr. Infect. Dis. J., Nov;25(11):987-94 (2006)
Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.
Ann. Allergy Asthma Immunol., Oct;97(4):457-63 (2006)
Treatment of experimental chronic pulmonary mycoplasmosis.
Int. J. Antimicrob. Agents., Sep;28(3):253-8 (2006)
Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes.
Ann. N. Y. Acad. Sci., Dec;1062:146-54 (2005)
Respiratory syncytial virus infections: old challenges and new opportunities.
Pediatr. Infect. Dis. J., Nov;24(11 Suppl):S189-96, discussion S196-7 (2005)
Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.
Antimicrob. Agents Chemother., Nov;49(11):4700-7 (2005)
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Virol. J., 2:46 (2005)
Respiratory syncytial virus pneumonia: mechanisms of inflammation and prolonged airway hyperresponsiveness.
Curr. Opin. Infect. Dis., Jun;18(3):199-204 (2005)
Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections.
J. Infect. Dis., Apr;191(7):1105-15 (2005)
Respiratory syncytial virus: old challenges and new approaches.
Pediatr Ann., Jan;34(1):62-8 (2005)
Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.
Pediatr. Infect. Dis. J., Aug;23(8):707-12 (2004)
Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Antimicrob. Agents Chemother., Aug;48(8):2897-904 (2004)
Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro.
Antimicrob. Agents Chemother., Aug;48(8):2825-30 (2004)
Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
J. Infect. Dis., May;189(10):1856-65 (2004)
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
Antimicrob. Agents Chemother., May;48(5):1811-22 (2004)